Category: How It Works
Every thought, mood and movement crosses a gap smaller than a wavelength of light. Here is how neurotransmitters carry the signal, what the famous ones really do, and why "low serotonin" is a slogan, not a mechanism.
Category: Mechanisms | Reading time: ~13 min | Level: Intermediate
Every mood you have ever felt, every decision, every flinch and every daydream, came down to molecules jumping a gap narrower than a wavelength of visible light. Neurons do not actually touch where they meet. They leave a deliberate space, and the entire drama of a functioning brain plays out in the act of ferrying chemical messengers across that space, again and again, billions of times a second. It is a strangely physical fact for something as ethereal as a thought.
The popular version of this story has collapsed into a single slogan: you feel low because your serotonin is low. It is a comforting shape, a broken level to top up, but it is closer to a marketing summary than to how the machinery works. The real system is more interesting and more useful to understand, because it explains things the slogan cannot, including why medicines that raise serotonin in hours can take weeks to lift a mood.
This piece walks the signal across the gap: how the synapse fires, what the famous neurotransmitters actually do, why reuptake is the quiet control knob, and where the low-serotonin story earns its scepticism.
A neurotransmitter is a chemical messenger that one neuron releases to pass a signal to another. The single mechanism sentence to hold onto is that a neuron's electrical signal cannot leap the gap between cells directly, so it is converted into a chemical one, sent across, and converted back.
Here is the sequence. A neuron carries information as an electrical impulse travelling down its length. When that impulse reaches the neuron's far end, it cannot simply continue into the next cell, because there is a physical gap in the way, the synapse. Instead, the arriving impulse triggers the release of neurotransmitter molecules, which have been stored in tiny packets, into that gap [1]. The molecules drift across in well under a millisecond and bind to receptors on the receiving neuron. That binding changes the receiving cell, nudging it closer to firing or further from it, and so the message continues. The gap is bridged by chemistry, and then, crucially, the gap is cleared so the next signal can be read cleanly.
It is worth slowing down the moment of transmission, because everything else depends on it. When the electrical impulse reaches the sending terminal, it opens channels that let calcium rush in. That calcium is the trigger: it causes the packets of neurotransmitter, called vesicles, to fuse with the cell membrane and empty their contents into the synaptic gap [1]. This is one of the fastest and most precisely timed events in biology, the last millisecond in the life of a vesicle.
The released molecules cross the gap and bind receptors on the receiving cell. This is where a common misconception dissolves. The effect of a neurotransmitter is not fixed by the molecule alone; it is set by the receptor it meets. The same neurotransmitter can bind several different receptor types, and different receptors produce different, sometimes opposite, responses. One receptor may make the receiving cell more likely to fire, another less likely. The sender proposes; the receiver decides.
Then the signal must end. If neurotransmitter lingered in the gap, the message would smear into noise. So the molecules are cleared, and the main way that happens is reuptake, which we will come to, because it is where a great deal of medicine and misunderstanding lives.
Before the celebrity neurotransmitters, meet the two that do most of the actual work. The brain runs on a balance between excitation and inhibition, and two molecules dominate that balance [2].
Glutamate is the principal excitatory neurotransmitter. When it binds its receptors, it makes the receiving neuron more likely to fire. It is the accelerator, and the great majority of fast signalling in the brain runs on it.
GABA, gamma-aminobutyric acid, is the principal inhibitory neurotransmitter and the brain's main brake. When it binds its receptors, it makes the receiving neuron less likely to fire, damping activity down. GABA is the reason your brain does not seize into runaway excitation, and it is the target of several calming and sedative medicines, which work by enhancing GABA's braking action.
Almost everything the brain does is a negotiation between this brake and this accelerator. The molecules with famous names, serotonin and dopamine, mostly work by modulating this underlying traffic rather than carrying the bulk of it themselves. Keep that hierarchy in mind: GABA and glutamate are the engine, the rest are the tuning.
Serotonin is involved in mood, sleep, appetite, and a long list of other functions, and in the brain it largely acts as a modulator, adjusting the gain on wider circuits rather than firing fast point-to-point messages [3]. It binds a whole family of different receptor subtypes, which is why its effects are so varied and so hard to reduce to one function. Most of the body's serotonin is actually made in the gut, where it regulates the movement of the intestine, but that serotonin does not cross into the brain in meaningful quantity, so the two pools are largely separate.
Dopamine is the other headline modulator, and it is routinely mislabelled as the pleasure chemical. The better-supported picture is that dopamine signals prediction: it tracks the difference between the reward you expected and the reward you got, spiking when things turn out better than predicted and dipping when they turn out worse [4]. That prediction signal is how the brain learns what is worth pursuing, which is why anticipation can move dopamine more than the reward itself. Dopamine also has a central role in initiating movement, a role entirely separate from mood, which is a useful reminder that these molecules are not single-purpose.
The lesson across both is the same. No neurotransmitter is a mood-in-a-molecule. Each acts across many circuits, through many receptors, doing different jobs in different places.
Once a neurotransmitter has delivered its message, it has to be removed from the gap, and the dominant mechanism is reuptake: the sending neuron pumps its own neurotransmitter back inside using dedicated transporter proteins, ending the signal and recycling the molecule for reuse. Reuptake is not glamorous, but it is arguably the most important control point in the whole system, because it sets how long a signal lasts.
This is exactly where a large class of medicines acts. Reuptake inhibitors block the transporter, so the neurotransmitter is not cleared as quickly and stays active in the synapse for longer. The best-known examples increase serotonin availability by blocking its reuptake. Understanding this makes one of the great puzzles of the field visible: these medicines raise serotonin in the synapse within hours, yet any mood benefit typically takes weeks to appear [5]. If low serotonin were simply the problem, topping it up should work fast. The long delay tells us the immediate rise is not the mechanism of benefit. Something slower is: receptors adjusting their sensitivity, and circuits gradually remodelling in response to the changed signalling.
Reuptake, in other words, is where the simple story breaks and the real one begins.
The idea that low mood is caused by low serotonin, often called the chemical imbalance theory, became a cultural fact long before the evidence settled. A large review that gathered the available studies found no consistent evidence that low mood is caused by reduced serotonin activity or concentration [5]. That does not mean serotonin is irrelevant, and it does not mean medicines that act on it do not help some people; many find them genuinely useful. It means the causal slogan, a chemical running low that a pill refills, is not what the data support.
Why does the slogan fail? Because mood and cognition are properties of whole circuits, not levels of a single chemical. They depend on how neurons are wired, how sensitive their receptors are, how the brain has adapted over time, and how systems like stress hormones and sleep feed in. A neurotransmitter is one variable in a system with many, and the system, not the variable, produces the experience.
The honest position is nuanced rather than dismissive. Neurotransmitters are real and central; the machinery in this article is well established. What is oversimplified is the leap from that machinery to a one-chemical explanation of a mood. Holding both at once, respecting the mechanism while distrusting the slogan, is the whole point.
Understanding the synapse changes what you expect from interventions, and lowers your susceptibility to a common style of overclaim.
Be sceptical of "floods your brain with X" marketing. The blood-brain barrier tightly controls what reaches the brain, and swallowing a neurotransmitter or a precursor does not straightforwardly raise its brain level. Products promising to top up a specific brain chemical are usually overstating a barrier that exists precisely to prevent that.
Think in circuits and habits, not levels. The levers with the best evidence for supporting mood and cognition act on the whole system: sleep, physical activity, daylight, social connection and managing chronic stress. These shape neurotransmitter systems indirectly and durably, which is more than most single supplements can claim.
Give slow processes time. Because benefit often comes from the brain adapting rather than a level changing, meaningful change in mood or cognition tends to take weeks, whether the lever is a medicine, a habit or a supplement. Fast promises should raise an eyebrow.
If your mood or thinking is persistently affecting your life, that is a conversation for a clinician rather than a supplement to guess at. Pregnant, breastfeeding, or on medication? Check with a healthcare professional first before starting any supplement that claims to act on brain chemistry, since several interact with prescribed medicines that affect the same systems.
The value of knowing how the synapse actually works is that it retires an entire genre of overclaim. Once you understand that effect depends on receptors, that the barrier guards what reaches the brain, and that benefit usually comes from slow adaptation rather than a topped-up level, the pill that promises to fix your mood by refilling one chemical loses its grip.
That is the kind of literacy the Remedy Library and Remy are meant to support: not a serotonin shortcut, but an honest reading of which levers have real mechanistic and clinical support for mood, sleep and focus, and which are trading on a slogan the science has moved past. If you want to see how the gut side connects to all this, the gut-brain axis mechanism guide is the natural companion read.
The gap between your neurons is not a flaw to be bridged with a supplement. It is where the brain does its most precise work, and the more accurately you picture that work, the harder you are to sell a story that a single molecule explains you.
1. Südhof TC. Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron. 2013. (Review of synaptic release.) 2. Bak LK, Schousboe A, Waagepetersen HS. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. Journal of Neurochemistry. 2006. (Review.) 3. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annual Review of Medicine. 2009. (Review.) 4. Schultz W. Multiple dopamine functions at different time courses. Annual Review of Neuroscience. 2007. (Review.) 5. Moncrieff J, Cooper RE, Stockmann T, et al. The serotonin theory of depression: a systematic umbrella review of the evidence. Molecular Psychiatry. 2023. (Umbrella review.)
They are chemical messengers that neurons use to talk to each other. When one neuron fires, it releases a neurotransmitter across the tiny gap to the next cell, where it binds a receptor and passes the message on. Different neurotransmitters carry different kinds of signals, some exciting the next cell, some calming it.
Through the synapse. An electrical impulse arriving at the end of one neuron triggers the release of neurotransmitter molecules into the synaptic gap. Those molecules drift across and bind receptors on the receiving cell, which converts the chemical message back into an electrical one. The gap is crossed by chemistry, not by direct contact.
GABA is the brain's main brake, reducing neural firing and promoting calm. Serotonin tunes mood, sleep and appetite among other roles. Dopamine drives motivation, reward learning and movement. None of them is simply a happiness or calm chemical; each acts across many circuits and depends on which receptors it meets.
Reuptake is the recycling of a neurotransmitter back into the neuron that released it, which ends the signal. It matters because it controls how long the message lasts. Several widely used medicines work by slowing reuptake, leaving a neurotransmitter active in the synapse for longer.
The simple "chemical imbalance" story is an oversimplification. Serotonin is involved in mood, but mood arises from whole circuits, receptor changes and how the brain adapts over time, not from a single chemical running low. Medicines that raise serotonin can help some people, but that does not prove a deficiency was the cause.
Only indirectly and modestly. The blood-brain barrier tightly controls what reaches the brain, and taking a neurotransmitter or its precursor does not straightforwardly raise brain levels. Diet and lifestyle nudge the system rather than dialling it, and strong claims about supplements flooding the brain with a given chemical usually overstate the biology.
Because the effect depends on the receptor, not just the molecule. A single neurotransmitter can bind several different receptor types, some of which excite the receiving cell and some of which inhibit it. The message is written as much by the receiver as by the sender.
This is one of the strongest clues that the simple low-serotonin story is incomplete. Reuptake-blocking medicines increase serotonin in the synapse within hours, yet mood effects typically take weeks. The lag points to slower downstream changes, such as receptors adjusting their sensitivity and circuits gradually remodelling, rather than a chemical simply being topped up. The brain adapts to the change over time, and it is that adaptation, not the immediate rise, that seems to track with benefit.
This is genuinely uncertain and often overstated. GABA taken by mouth does not cross the blood-brain barrier well, so it is unlikely to raise brain GABA directly the way the marketing implies. Any calming effect people report may come from other routes, including action on the nervous system in the gut, or from expectation. The mechanism sold on the label is not the mechanism the biology best supports, so treat confident claims with caution.
It is a half-truth worth correcting. Dopamine is less about the pleasure of a reward and more about prediction: it signals when an outcome is better or worse than expected, which is how the brain learns what is worth pursuing. That is why anticipation can spike dopamine more than the reward itself. Calling it simply the pleasure chemical misses the more interesting and better-supported role it plays in motivation and learning.